Drug Combination Details
| General Information of the Combination (ID: C02110) | |||||
|---|---|---|---|---|---|
| Name | Cucurbitacin I NP Info | + | 5-fluorouracil Drug Info | ||
| Structure |
|
+ |
|
||
| Disease |
Colon cancer
[ICD-11: 2B90]
|
Investigative | [1] | ||
| Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
|---|---|---|---|---|---|---|
| α. Enhancing Drug Efficacy by This Combination | ||||||
| Achieving Therapeutic Synergy | Click to Show/Hide | |||||
| Experiment 1 Reporting the Effect of This Combination | [1] | |||||
| In-vitro Model | COLO 205 | CVCL_0218 | Colon adenocarcinoma | Homo sapiens | ||
| Experimental
Result(s) |
Cucurbitacin I inhibits cell migration and invasion and enhances chemosensitivity in colon cancer. | |||||
| References | ||||
|---|---|---|---|---|
| Reference 1 | Cucurbitacin I inhibits cell migration and invasion and enhances chemosensitivity in colon cancer. Oncol Rep. 2015 Apr;33(4):1867-71. | |||
